Epidermal growth factor receptor and programmed cell death-1 expression levels in peripheral T cell subsets of patients with non-small cell lung cancer.

Autor: Ceylan A; Division of Immunology and Allergy, Department of Pediatrics, Faculty of Medicine, Selcuk University, Konya, Turkey., Artac M; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Kocak MZ; Department of Medical Oncology, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey., Artac H; Division of Immunology and Allergy, Department of Pediatrics, Faculty of Medicine, Selcuk University, Konya, Turkey.

Publikováno v: Scandinavian journal of immunology [Scand J Immunol] 2024 Oct; Vol. 100 (4), pp. e13398. Date of Electronic Publication: 2024 Jul 29.

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study.

Autor: Tokito T; Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan. tokitou_takaaki@kurume-u.ac.jp., Kolesnik O; Zaporizhzhya Regional Clinical Oncology Center, Zaporizhzhya State Medical University, Zaporozhye, Ukraine., Sørensen J; Department of Oncology, Centre for Cancer and Organ Diseases, Rigshospitalet, Copenhagen, Denmark., Artac M; Department of Medical Oncology, Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi, Konya, Turkey., Quintela ML; Department of Medical Oncology, Hospital Álvaro Cunqueiro-Complexo Hospitalario Universitario de Vigo, Vigo, Spain., Lee JS; Division of Hematology-Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Hussein M; Florida Cancer Specialists, Tavares, FL, USA., Pless M; Department of Medical Oncology, Kantonsspital Winterthur, Winterthur, Switzerland., Paz-Ares L; Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Universidad Complutense & Ciberonc, Madrid, Spain., Leopold L; Incyte Corporation, Wilmington, DE, United States., Daniel J; Incyte Corporation, Wilmington, DE, United States., Munteanu M; Incyte Corporation, Wilmington, DE, United States., Samkari A; Merck & Co., Inc., Rahway, NJ, United States., Xu L; Merck & Co., Inc., Rahway, NJ, United States., Butts C; Department of Oncology, Division of Medical Oncology, Cross Cancer Institute, Edmonton, Canada.

Publikováno v: BMC cancer [BMC Cancer] 2024 Jul 25; Vol. 23 (Suppl 1), pp. 1251. Date of Electronic Publication: 2024 Jul 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers.

Autor: Kunt N; Department of Internal Medicine, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey. nazlikuntt@gmail.com., Araz M; Department of Oncology, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey., Yildirim MS; Department of Medical Genetics, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey., Findik S; Department of Pathology, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey., Kocak MZ; Department of Oncology, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey., Eryilmaz MK; Department of Oncology, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey., Artac M; Department of Oncology, Faculty of Medicine, Necmettin Erbakan University Meram, Saraykoy Akyokus Street 42080, Konya, Turkey.

Publikováno v: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2023 Dec; Vol. 54 (4), pp. 1316-1321. Date of Electronic Publication: 2023 May 16.

Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio.

Autor: Kocak MZ; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey. mehmetzahidkocak@hotmail.com., Coban S; Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey., Araz M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Eryilmaz MK; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Artac M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 May 29; Vol. 31 (6), pp. 357. Date of Electronic Publication: 2023 May 29.